Delcath Systems - 2003 News Archive

2003 Archive

March 4, 2003
Delcath Receives Ethics Committee Approval For Phase III Liver Tumor Study At Sydney Melanoma Unit

March 11, 2003
Australian Government Approves Phase III Delcath Liver Tumor Study

March 23, 2003
Delcath Selects Omnicare to Manage Phase III Cancer Trial at Australia's Leading Melanoma Treatment Unit

April 28, 2003
Delcath CEO Presents at CEOCast Life Sciences Conference

May 1, 2003
National Cancer Institute Study Of Delcath Cancer Treatment To Be Presented at ASCO

May 15, 2003
DELCATH ANNOUNCES A PUBLIC OFFERING OF SECURITIES

May 22, 2003
Delcath Systems Completes Public Offering

June 3, 2003
NCI Researchers Report Significant Anti-Tumor Activity In Small Study with Delcath System

June 5, 2003
Delcath Reports On 2003 Annual Meeting

June 16, 2003
Delcath Underwriters Exercise Over-Allotment

November 13, 2003
Delcath Files 10Q for Period Ending September 30 2003

Delcath News

June 13, 2007
Delcath Fulfills Nasdaq Independent Director and Audit Committee Requirements With Addition of Two New Directors

June 5, 2007
Delcath Updates Clinical Trials

June 5, 2007
Jonathan J. Lewis, MD Joins Delcath's Board of Directors

May 30, 2007

Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Center

May 24, 2007

Delcath Systems Names Laura A. Philips to Board of Directors

May 24, 2007

Delcath Systems Adds Two Executives

May 17, 2007

Delcath Systems Announces Presentation of Data at World Conference on Interventional Oncology

May 16, 2007
Delcath Systems Issues CEO Letter to Shareholders

May 10, 2007
DELCATH SYSTEMS FILES FIRST QUARTER 2007 10-Q AND SHELF REGISTRATION

April 17, 2007
Delcath Systems Announces Board Resignations

April 10, 2007
DELCATH SYSTEMS ENTERS MODIFICATION AGREEMENT WITH LADDCAP AND MODIFIES STOCKHOLDER RIGHTS PLAN

Stock Quote

Delcath stock tracker

Most recent trade:$1.03

Today's Change:-0.11

(Prices delayed up to 20 minutes.)